Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed and Refractory B-cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06533579
What this trial is testing

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Who this might be right for
B-cell Acute Lymphoblastic LeukemiaLarge B-cell LymphomaChronic Lymphocytic Leukemia+10 more
Vironexis Biotherapeutics Inc. 32
Testing effectiveness (Phase 2)Study completedNCT00027560
What this trial is testing

Melphalan, Fludarabine, and Alemtuzumab Followed by Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Memorial Sloan Kettering Cancer Center 51
Not applicableLooking for participantsNCT07236203
What this trial is testing

Predictive Factors for the Efficacy of CD19 CAR-T Therapy in Relapsed/Refractory Large B-Cell Lymphoma: A Clinical Study

Who this might be right for
Large B-Cell Lymphoma
Fudan University 80
Not applicableActive Not RecruitingNCT07777120
What this trial is testing

Liso-Cel in Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Bristol-Myers Squibb 300
Testing effectiveness (Phase 2)Ended earlyNCT04433182
What this trial is testing

Copanlisib With Rituximab-Bendamustine in Patients With Relapsed-Refractory Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Fondazione Italiana Linfomi - ETS 37
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07020260
What this trial is testing

The PACMAN-Hu19 Trial: a Study of the Safety and Feasibility of Locally Produced, CD19-targeted and Human CAR T-cell Therapy in Children and Young Adults With Relapsed or Refractory B-cell Malignancies

Who this might be right for
LeukemiaLymphoma
Princess Maxima Center for Pediatric Oncology 18
Early research (Phase 1)Not Yet RecruitingNCT07316920
What this trial is testing

A Clinical Study of of RN1701 Injection in the Treatment of Relapsed/Refractory B-Cell Lymphomas

Who this might be right for
Relapsed/Refractory B-cell Lymphoma
YANRU WANG 19
Early research (Phase 1)UnknownNCT03921879
What this trial is testing

Safety and Efficacy of OT-82 in Participants With Relapsed or Refractory Lymphoma

Who this might be right for
LymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more
Oncotartis, Inc. 50
Testing effectiveness (Phase 2)Study completedNCT00764517
What this trial is testing

Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Indolent Adult Non-Hodgkin Lymphoma+1 more
OHSU Knight Cancer Institute 57
Testing effectiveness (Phase 2)Study completedNCT00059995
What this trial is testing

MDX-060 Monoclonal Antibody in Treating Patients With Refractory or Relapsed Lymphoma

Who this might be right for
Lymphoma
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT04870853
What this trial is testing

Cardiovascular Events Among Adults Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Standard of Care Chimeric Antigen Receptor T Cell Therapy

Who this might be right for
Recurrent Aggressive B-Cell Non-Hodgkin LymphomaRecurrent Diffuse Large B-Cell LymphomaRecurrent High Grade B-Cell Lymphoma+7 more
M.D. Anderson Cancer Center 150
Early research (Phase 1)Looking for participantsNCT07774572
What this trial is testing

Exploration of Circular RNA in B-cell Hematologic Malignancies

Who this might be right for
Lymphoma, B-Cell Refractory
Ruijin Hospital 30
Early research (Phase 1)Ended earlyNCT02454270
What this trial is testing

A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+2 more
Janssen Research & Development, LLC 59
Testing effectiveness (Phase 2)Looking for participantsNCT06014073
What this trial is testing

TRAC and Power3 (SPPL3) Genes Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-NHL

Who this might be right for
Non Hodgkin's Lymphoma
Chinese PLA General Hospital 30
Not applicableLooking for participantsNCT06788639
What this trial is testing

Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing Setting

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 300
Testing effectiveness (Phase 2)Study completedNCT01427881
What this trial is testing

Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more
Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Study completedNCT01980628
What this trial is testing

Study of the Bruton's Tyrosine Kinase Inhibitor in Subjects With Relapsed/Refractory Marginal Zone Lymphoma

Who this might be right for
Marginal Zone LymphomaB-cell Lymphoma
Pharmacyclics LLC. 63
Testing effectiveness (Phase 2)UnknownNCT00740467
What this trial is testing

Stem Cell Transplant in Treating Patients With Hematological Cancer or Other Disorders

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Institut Paoli-Calmettes 50
Early research (Phase 1)WithdrawnNCT02238522
What this trial is testing

Phase 1 Study Evaluating ZEN003365 in Relapsed/Refractory Lymphoproliferative Malignancies or Relapsed/Refractory AML

Who this might be right for
Lymphoproliferative MalignanciesAcute Myeloid Leukemia
Zenith Epigenetics
Testing effectiveness (Phase 2)Study completedNCT01965119
What this trial is testing

Pilot Study of Ruxolitinib in Relapsed or Refractory Hodgkin Lymphoma and Primary Mediastinal Large B-cell Lymphoma

Who this might be right for
Relapsed or Refractory Hodgkin LymphomaPrimary Mediastinal Large B-cell Lymphoma
Samsung Medical Center 20
Next Page